Shanghai Allist Pharmaceuticals Hits Day High with 5.71% Surge

Shanghai Allist Pharmaceuticals Co., Ltd. has experienced a significant uptick in its stock performance, gaining 5.71% on March 27, 2026. The stock reached an intraday high of CNY 97.24, showcasing its strong market activity. This performance stands in contrast to the China Shanghai Composite, which only rose by 0.63% on the same day. Over the past week, Shanghai Allist Pharmaceuticals has shown a robust increase of 7.28%, while the broader market has declined by 1.09%. The company has also demonstrated resilience over the past month, with a 4.41% gain compared to a 5.99% drop in the China Shanghai Composite. Financially, Shanghai Allist Pharmaceuticals boasts impressive metrics, including a net profit of CNY 1,187.76 million, reflecting a growth rate of 59.72%. The company has maintained a strong return on equity (ROE) of 29.94% and a return on capital employed (ROCE) of 34.9%. With a market capitalization of CNY 43,056 million, the company continues to solidify its position within the pharmaceuticals and biotechnology sector.